Brief: Pharmaust Says Unit Epichem Awarded Contract Extension
15/12/2021 01:33
Dec 15 (Reuters) - Pharmaust Ltd PAA.AX :
* UNIT EPICHEM AWARDED CONTRACT EXTENSION, EXPECTED TO
GENERATE UP
TO A$1.02M IN REVENUES FOR EPICHEM DURING CY2022
Source text for Eikon: ID:nASX29jwsC
Further company coverage: PAA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility